Delivery Order SPE2DB22D1106-SPE2DB25FEJM4
Award Date
4/18/25
Potential Completion Date
4/21/25
Potential Value
$3.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,037.40, is for the supply of EMGALITY 120 MG/ML PENML, a prescription medication. The contract is a firm fixed-price delivery order with a completion date of May 16, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EMGALITY 120 MG/ML PENML, a prescription medication. The contract has a ceiling value of $1,729.00 and a period of performance through April 17, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,037.40, is for the supply of the medication EMGALITY 120 MG/ML PENML. The contract has an ultimate completion date of May 30, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,671.20, is for the supply of EMGALITY 120 MG/ML PENML, a prescription medication. The delivery order has a firm fixed price and is set to be completed by October 25, 2024. While the original solicitation is not provided, the contract is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a $1,037.40 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of EMGALITY 120 MG/ML SYRINGEML. The contract has an ultimate completion date of June 9, 2025 and is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,113.47 firm fixed-price contract is for the delivery of EMGALITY 120 MG/ML PENML, a pharmaceutical product, with a completion date of January 27, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,729.00, is for the supply of EMGALITY 120 MG/ML PENML, a specialty medication. The contract has a firm fixed price pricing type and an ultimate completion date of December 2, 2024. This delivery order is a part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,416.08, is for the supply of EMGALITY 120 MG/ML PENML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of April 1, 2025. There is no set-aside designation indicated for this award. Amerisourcebergen Drug Corp...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of EMGALITY 120 MG/ML PENML, a specialty medication. The contract has a ceiling value of $1,868.28 and an ultimate completion date of March 17, 2022. This award is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
This is a $1,107.72 firm fixed-price delivery order contract awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EMGALITY 120 MG/ML PENML, with a period of performance through May 27, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, which provides a...